For instance, in lung cancer research, organoids have been instrumental in drug screening, leading to the discovery of Manoalide (MA) as an agent that sensitizes KRAS-mutated and osimertinib-resistant lung cancer to EGFR-TKIs. Here, KRAS is linked to lung carcinoma.